Michael Green

Michael Green

Auto-generated profile, based on publicly available information

Michael Green

Departments of Pediatrics and Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2013 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
MGM. Green
M. Green
MMM. G. Michaels
M. G. Michaels
Epstein-Barr virus (EBV) is an important pathogen in recipients of solid organ transplants (SOT). Infection with EBV manifests as a spectrum of diseases/malignancies ranging from asymptomatic viremia through infectious mononucleosis to posttransplant lymphoproliferative disorder (PTLD). EBV disease and its associated PTLD is more frequently seen when primary EBV infection occurs after transplant, a common scenario in pediatric SOT recipients. Intensity of immunosuppressive therapies also influences the risk for PTLD. The use of EBV viral load monitoring facilitates the diagnosis and management of EBV/PTLD as well as being used to inform preemptive therapy with reduction of immunosuppression, the most effective intervention for prevention of and treatment for PTLD. Other therapies, including the rituximab (anti-CD20 monoclonal antibody) and traditional chemotherapy, are also useful in the treatment of established PTLD. The future development of standards for management based on EBV viral load and routine monitoring of EBV-specific CTL responses promise further improvement in outcomes with EBV and PTLD.

30 December 2022 in American Journal of Transplantation
Verified
Journal Article
Open access
MMMarian G. Michaels
Marian G. Michaels
RHRicardo M. La Hoz
Ricardo M. La Hoz
LDLara Danziger-Isakov
Lara Danziger-Isakov
EBEmily A. Blumberg
Emily A. Blumberg
DKDeepali Kumar
Deepali Kumar
CWCameron R. Wolfe
Cameron R. Wolfe
The recent identification of an outbreak of 2019- novel Coronavirus is currently evolving, and the impact on transplantation is unknown. However, it is imperative that we anticipate the potential impact on the transplant community in order to avert severe consequences of this infection on both the transplant community and contacts of transplant patients.

6 March 2013 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
MGM. Green
M. Green
Click on the article title to read more.

1 August 2006 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
MGM. Green
M. Green
MMM. G. Michaels
M. G. Michaels
BKB. Z. Katz
B. Z. Katz
MBM. Burroughs
M. Burroughs
DGD. Gerber
D. Gerber
JRJ. Reyes
J. Reyes
A randomized controlled trial of CMV-IVIG (cytomegalovirus-intravenous immunoglobulin) for prevention of Epstein Barr virus (EBV) posttransplant lymphoproliferative disease (PTLD) in pediatric liver transplantation (PLTx) recipients was begun in Pittsburgh and subsequently expanded to four additional sites. Protocol EB viral loads were obtained in a blinded fashion; additional loads could be obtained for clinical indications. Patients were followed for 2 years post-LTx. Eighty-two evaluable patients (39 CMV-IVIG, 43 placebo) developed 18 episodes of EBV disease (7 CMV-IVIG, 11 placebo) including nine cases of PTLD (three CMV-IVIG, six placebo). No significant differences were seen in the adjusted 2-year EBV disease-free rate (CMV-IVIG 79%, placebo 71%) and PTLD-free rate (CMV-IVIG 91%, placebo 84%) between treatment and placebo groups at 2 years (p > 0.20). The absence of significant effect of CMV-IVIG may be explained by a lack of efficacy of the drug or limitations of sample size.

9 September 2019 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
SSSneha Suresh
Sneha Suresh
JUJulia Upton
Julia Upton
MGMichael Green
Michael Green
APAnne Pham‐Huy
Anne Pham‐Huy
KPKlara M. Posfay‐Barbe
Klara M. Posfay‐Barbe
UAUpton D. Allen
Upton D. Allen

2 April 2009 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
MGMichael Green
Michael Green
KSKyle Soltys
Kyle Soltys
DRDavid T. Rowe
David T. Rowe
SWSteven A. Webber
Steven A. Webber
GMGeorge Mazareigos
George Mazareigos